Trinity Biotech (TRIB) Stock Price

Trinity Biotech Price

Düsseldorf·CLOSED
10.98USD-0.23 (-2.03 %)
Market closed

Revenue at Trinity Biotech has contracted by 2.4% per year over the past 19 years to 61.56 M USD. Earnings per share have declined at 20.4% per year over the last 16 years. For Trinity Biotech, the net margin of -51.6% is down versus -6.3% a few years ago. At today's price the dividend yield works out to roughly 2.00%. The payout ratio is around 109% of earnings. The dividend has grown at 21.8% per year over the past 4 years. The consensus 12-month price target for Trinity Biotech is 4.08 USD, about 62.8% below where the stock trades today. Of 7 analysts, 6 rate the stock a buy — an overall Buy consensus. The stock trades about 28% above its 52-week low.

Trinity Biotech stock price

Volume
Ex-Dividend
Details

Stock Price

ⓘ

How to Read This Chart

This chart tracks the historical stock price of Trinity Biotech over time. You can switch between daily, weekly, and monthly views and select custom time ranges — from a single day to the full available history. Use the toggle to view price changes in absolute currency terms or as a percentage change relative to the starting date.

Total Return vs. Price Return

The "Total Return" toggle includes reinvested dividends on top of the pure price movement. This is critical because dividends can account for a significant portion of long-term returns. Historically, roughly 40 % of the S&P 500's total return has come from dividends. Always compare total return when evaluating a stock's real performance against a benchmark.

Intraday Price Data

When viewing a one-day time frame, the chart displays real-time intraday price movements. This is useful for observing how Trinity Biotech stock reacts to market openings, earnings releases, or breaking news throughout the trading session.

What to Look For

Look for long-term trends (sustained upward or downward movements over months and years), support and resistance levels (price zones where the stock repeatedly bounces or reverses), and volatility (how much the price fluctuates day to day). Comparing Trinity Biotech's price chart to a market index like the S&P 500 can reveal whether the stock is outperforming or underperforming the broader market.

Trinity Biotech Stock Price History
DateTrinity Biotech Price
8/5/202610.98 USD
8/4/202611.20 USD
8/3/202611.13 USD
7/31/202611.60 USD
7/30/202612.75 USD
7/29/202612.98 USD
7/27/20268.79 USD
7/23/20268.60 USD
7/21/202610.80 USD
7/20/202610.20 USD
7/17/202610.20 USD
7/16/202611.10 USD
7/15/202610.80 USD
7/14/202610.20 USD
7/13/202610.66 USD
7/10/202611.70 USD
7/9/202611.74 USD
7/8/202611.42 USD
7/7/202611.96 USD
7/6/202610.90 USD
7/2/202611.40 USD
7/1/202610.71 USD
6/30/202611.66 USD
6/29/202612.53 USD
6/26/202610.80 USD
6/25/202610.47 USD
6/24/202610.26 USD
6/23/202610.66 USD
6/22/202610.66 USD
6/18/202610.48 USD
6/17/202610.48 USD
6/16/202610.30 USD
6/15/202612.28 USD
6/12/202611.74 USD
6/11/202612.28 USD
6/10/202612.47 USD
6/9/202611.92 USD
6/8/202612.28 USD
6/5/202612.10 USD
6/4/202612.28 USD
6/3/202612.65 USD
6/2/202613.19 USD
6/1/202613.01 USD
5/29/202612.65 USD
5/28/202612.65 USD
5/27/202612.28 USD
5/26/202611.74 USD
5/22/202610.84 USD
5/21/202611.38 USD
5/20/202610.84 USD
5/19/202610.30 USD
5/18/202610.30 USD
5/15/202610.30 USD
5/14/202610.48 USD
5/13/202610.66 USD
5/12/202610.66 USD
5/11/202610.84 USD
5/8/202611.02 USD
5/7/202610.66 USD
5/6/202610.84 USD
5/5/202610.84 USD
5/4/202611.20 USD
5/1/202611.02 USD
4/30/202610.84 USD
4/29/202610.84 USD
4/28/202611.02 USD
4/27/202611.56 USD
4/24/202611.56 USD
4/23/202611.92 USD
4/22/202612.83 USD
4/21/202612.65 USD
4/20/202613.37 USD
4/17/202613.55 USD
4/16/202612.65 USD
4/15/202612.65 USD
4/14/202613.01 USD
4/13/202612.65 USD
4/10/202612.83 USD
4/9/202612.65 USD
4/8/202610.84 USD
4/7/202611.02 USD
4/6/202611.20 USD
4/2/202610.84 USD
4/1/202610.84 USD
3/31/20269.76 USD
3/30/202610.12 USD
3/27/202610.84 USD
3/26/202611.02 USD
3/25/202611.02 USD
3/24/202611.02 USD
3/23/202610.84 USD
3/20/202611.56 USD
3/19/202611.74 USD
3/18/202612.47 USD
3/17/202613.37 USD
3/16/202614.63 USD
3/13/202613.91 USD
3/12/202612.47 USD
3/11/202613.01 USD
3/10/202611.74 USD
3/9/202612.65 USD
3/6/202613.19 USD
3/5/202613.19 USD
3/4/202612.65 USD
3/3/202612.47 USD
3/2/202612.47 USD
2/27/202613.01 USD
2/26/202613.01 USD
2/25/202613.55 USD
2/24/202613.55 USD
2/23/202612.65 USD
2/20/202612.83 USD
2/19/202613.37 USD
2/18/202613.73 USD
2/17/202613.91 USD
2/13/202613.91 USD
2/12/202614.27 USD
2/11/202614.81 USD
2/10/202615.72 USD
2/9/202614.45 USD
2/6/202614.45 USD
2/5/202612.83 USD
2/4/202614.09 USD
2/3/202614.09 USD
2/2/202614.81 USD
1/30/202614.81 USD
1/29/202615.90 USD
1/28/202616.44 USD
1/27/202616.98 USD
1/26/202616.44 USD
1/23/202616.44 USD
1/22/202614.27 USD
1/21/202612.65 USD
1/20/202612.65 USD
1/16/202612.47 USD
1/15/202612.83 USD
1/14/202612.65 USD
1/13/202612.65 USD
1/12/202612.83 USD
1/9/202613.19 USD
1/8/202613.37 USD
1/7/202613.73 USD
1/6/202613.73 USD
1/5/202613.73 USD
1/2/202613.55 USD
12/31/202514.27 USD
12/30/202514.81 USD
12/29/202514.81 USD
12/26/202518.07 USD
12/24/202518.43 USD
12/23/202523.12 USD
12/22/202516.08 USD
12/19/202516.26 USD
12/18/202516.98 USD
12/17/202516.80 USD
12/16/202517.16 USD
12/15/202516.98 USD
12/12/202519.33 USD
12/11/202519.33 USD
12/10/202520.60 USD
12/9/202521.68 USD
12/8/202519.87 USD
12/5/202517.34 USD
12/4/202518.07 USD
12/3/202518.07 USD
12/2/202518.25 USD
12/1/202518.43 USD
11/28/202518.97 USD
11/26/202517.70 USD
11/25/202516.08 USD
11/24/202516.08 USD
11/21/202514.99 USD
11/20/202514.99 USD
11/19/202515.18 USD
11/18/202514.81 USD
11/17/202514.81 USD
11/14/202515.90 USD
11/13/202515.36 USD
11/12/202516.26 USD
11/11/202516.26 USD
11/10/202516.98 USD
11/7/202517.16 USD
11/6/202517.34 USD
11/5/202517.89 USD
11/4/202518.07 USD
11/3/202517.70 USD
10/31/202518.07 USD
10/30/202518.07 USD
10/29/202517.89 USD
10/28/202518.07 USD
10/27/202518.43 USD
10/24/202518.07 USD
10/23/202517.16 USD
10/22/202516.26 USD
10/21/202517.34 USD
10/20/202518.61 USD
10/17/202517.89 USD
10/16/202518.43 USD
10/15/202519.87 USD
10/14/202519.33 USD
10/13/202519.51 USD
10/10/202518.97 USD
10/9/202520.41 USD
10/8/202519.15 USD
10/7/202519.33 USD
10/6/202519.87 USD
10/3/202520.78 USD
10/2/202519.15 USD
10/1/202518.43 USD
9/30/202518.79 USD
9/29/202518.97 USD
9/26/202519.33 USD
9/25/202520.41 USD
9/24/202520.60 USD
9/23/202520.41 USD
9/22/202521.68 USD
9/19/202521.50 USD
9/18/202521.86 USD
9/17/202521.32 USD
9/16/202521.68 USD
9/15/202521.50 USD
9/12/202521.50 USD
9/11/202521.68 USD
9/10/202520.96 USD
9/9/202519.87 USD
9/8/202520.23 USD
9/5/202520.96 USD
9/4/202520.78 USD
9/3/202524.03 USD
9/2/202525.29 USD
8/29/202526.38 USD
8/28/202527.82 USD
8/27/202526.74 USD
8/26/202526.56 USD
8/25/202528.00 USD
8/22/202528.36 USD
8/21/202528.18 USD
8/20/202531.44 USD
8/19/202524.75 USD
8/18/202528.36 USD
8/15/202529.27 USD
8/14/202534.51 USD
8/13/202518.25 USD
8/12/202520.41 USD
8/11/202514.99 USD
8/8/202516.62 USD
8/7/202516.08 USD
Access this data via the Eulerpool API
Get Free API Key

Trinity Biotech Revenue, EBIT, Net Income

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Revenue
EBIT
Net Income
Details
Date
Revenue
EBIT
Net Income
Jan 1, 2019
90.44 M USD
183,000.00 USD
-28.91 M USD
Jan 1, 2020
101.98 M USD
16.02 M USD
-6.39 M USD
Jan 1, 2021
81.15 M USD
6.46 M USD
875,000.00 USD
Jan 1, 2022
62.52 M USD
-13.52 M USD
-41.01 M USD
Jan 1, 2023
56.83 M USD
-15.94 M USD
-24.02 M USD
Jan 1, 2024
61.56 M USD
-16.06 M USD
-31.79 M USD
Jan 1, 2025 (e)
69.87 M USD
-6.11 M USD
-324.25 M USD
Jan 1, 2026 (e)
79.05 M USD
1.30 M USD
-176.53 M USD

Trinity Biotech Income Statement, Balance Sheet, Cash Flow Statement

Last updated Aug 7, 2026, 1:55 AM
 
REVENUEM USD
REVENUE GROWTH%
GROSS MARGIN%
GROSS INCOMEM USD
EBITM USD
EBIT MARGIN%
NET INCOMEM USD
NET INCOME GROWTH%
DIV.USD
DIV. GROWTH%
SHARESM
201120122013201420152016201720182019202020212022202320242025e2026e
77.0082.0091.00104.00100.0099.0099.0097.0090.00101.0081.0062.0056.0061.0069.0079.00
-13.486.4910.9814.29-3.85-1.00–-2.02-7.2212.22-19.80-23.46-9.688.9313.1114.49
51.9551.2249.4547.1246.0043.4341.4142.2742.2247.5240.7427.4233.9334.4334.4334.43
40.0042.0045.0049.0046.0043.0041.0041.0038.0048.0033.0017.0019.0021.0023.7527.20
15.0017.008.0015.0013.008.004.006.00–16.006.00-13.00-15.00-16.00-6.001.00
19.4820.738.7914.4213.008.084.046.19–15.847.41-20.97-26.79-26.23-8.701.27
15.0017.009.0017.0021.00-100.00-40.00-22.00-28.00-6.00–-41.00-24.00-31.00-324.00-176.00
-75.0013.33-47.0688.8923.53-576.19-60.00-45.0027.27-78.57––-41.4629.17945.16-45.68
––0.200.220.22–––––––––1.151.21
–––10.00–––––––––––5.22
17.7817.9618.7418.9721.9318.3717.3016.7283.6183.6183.61134.94153.10353.21353.21353.21
Details

Income Statement Key Figures

ⓘ

Revenue and Revenue Growth

Revenue is the starting point of every income statement — it measures the total sales Trinity Biotech generates from its core business. Revenue growth (expressed as year-over-year percentage change) is one of the most important indicators of business momentum. Sustained growth above 10 % annually is generally considered strong, while declining revenue is a serious warning sign that demands investigation.

Gross Margin

Gross margin = (Revenue − Cost of Goods Sold) ÷ Revenue. It reveals what percentage of each dollar of revenue Trinity Biotech retains after direct production costs. High gross margins (above 50 %) are typical of asset-light businesses like software and brands, while capital-intensive industries like manufacturing often operate below 30 %. Compare Trinity Biotech's gross margin to industry peers and track it over time to spot improving or deteriorating pricing power.

EBIT and EBIT Margin

EBIT measures operating profit — what remains after subtracting all operating expenses (including R&D, sales, and administrative costs) from gross profit. The EBIT margin shows this as a percentage of revenue. Because it excludes interest and taxes, EBIT allows fair comparisons between companies with different debt levels and tax jurisdictions. A rising EBIT margin indicates improving operational efficiency.

Net Income and Earnings Per Share (EPS)

Net income is the company's final profit after all expenses, interest, and taxes. Dividing net income by the number of shares outstanding gives you EPS — the single most influential metric in stock valuation. Consistent EPS growth is the primary driver of long-term stock price appreciation. Always check whether EPS growth comes from genuine profit improvement or from share buybacks reducing the share count.

Shares Outstanding

The total number of shares Trinity Biotech has issued. A declining share count (through buybacks) boosts EPS and signals management confidence. A rising share count (through stock issuance) dilutes existing shareholders. Always monitor this number alongside EPS to get the full picture of per-share value creation.

Analyst Estimates

The projected figures represent consensus estimates from professional analysts. Compare these forecasts against Trinity Biotech's historical growth rates to assess whether expectations are realistic. A company that consistently beats consensus estimates tends to see its stock price rewarded over time, while repeated misses erode investor confidence.

Trinity Biotech stock margins

The Trinity Biotech margin analysis displays the gross margin, EBIT margin, as well as the profit margin of Trinity Biotech. The EBIT margin (EBIT/sales) indicates the percentage of sales that remains as operating profit. The profit margin shows the percentage of sales that remains for Trinity Biotech.

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Gross margin
EBIT margin
Profit margin
Details
Date
Gross margin
EBIT margin
Profit margin
Jan 1, 2019
42.15 %
0.20 %
-31.97 %
Jan 1, 2020
47.64 %
15.71 %
-6.26 %
Jan 1, 2021
41.23 %
7.96 %
1.08 %
Jan 1, 2022
27.62 %
-21.62 %
-65.59 %
Jan 1, 2023
34.22 %
-28.05 %
-42.26 %
Jan 1, 2024
34.83 %
-26.09 %
-51.64 %
Jan 1, 2025 (e)
34.83 %
-8.75 %
-464.07 %
Jan 1, 2026 (e)
34.83 %
1.64 %
-223.32 %

Trinity Biotech Stock Revenue, EBIT, Earnings per Share

The Trinity Biotech earnings per share therefore indicates how much revenue Trinity Biotech has generated per share in a given period. The earnings before interest and taxes per share shows how much of the operating profit corresponds to each share. The earnings per share indicates how much of the profit belongs to each share.

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Revenue per Share
EBIT per share
Earnings per Share
Details
Date
Revenue per Share
EBIT per share
Earnings per Share
Jan 1, 2019
5.41 USD
0.01 USD
-1.73 USD
Jan 1, 2020
6.10 USD
0.96 USD
-0.38 USD
Jan 1, 2021
4.85 USD
0.39 USD
0.05 USD
Jan 1, 2022
2.32 USD
-0.50 USD
-1.52 USD
Jan 1, 2023
1.86 USD
-0.52 USD
-0.78 USD
Jan 1, 2024
0.87 USD
-0.23 USD
-0.45 USD
Jan 1, 2025 (e)
0.99 USD
-0.09 USD
-4.59 USD
Jan 1, 2026 (e)
1.12 USD
0.02 USD
-2.50 USD

Trinity Biotech business model & stock analysis

Trinity Biotech Segments

Trinity Biotech Revenue by Segment

  • 3 Years

  • Max

Clinical laboratory goods
Point-of-Care
Clinical laboratory services
Details
Date
Clinical laboratory goods
Point-of-Care
Clinical laboratory services
Jan 1, 2022
58.29 M USD
9.21 M USD
7.27 M USD
Jan 1, 2023
42.29 M USD
9.09 M USD
5.45 M USD
Jan 1, 2024
39.37 M USD
17.43 M USD
4.75 M USD

Trinity Biotech Revenue by Region

  • 3 Years

  • Max

Americas
Ireland
Eliminations
Details
Date
Americas
Ireland
Eliminations
Jan 1, 2022
76.62 M USD
25.10 M USD
-26.94 M USD
Jan 1, 2023
66.85 M USD
12.72 M USD
-22.74 M USD
Jan 1, 2024
61.61 M USD
20.47 M USD
-20.52 M USD

Trinity Biotech Eulerpool Fair Value

Details

Fair Value Estimate

ⓘ

What Is Fair Value?

Fair value is an estimate of what a stock is truly "worth" based on its financial fundamentals, independent of the current market price. If the calculated fair value is above the current share price, the stock may be undervalued — and vice versa. This chart shows three different fair value approaches so you can cross-check them against each other.

Earnings-Based Fair Value

Calculated by multiplying the current earnings per share (EPS) by the average historical P/E ratio over a selected multi-year period. The smoothing over several years filters out temporary spikes or dips. If this fair value exceeds the market price, it suggests the stock is cheap relative to its earning power.

Example: Fair Value (Earnings) 2022 = EPS 2022 × Average P/E 2019–2021

Revenue-Based Fair Value

Derived by multiplying revenue per share by the average historical price-to-sales ratio. This method is particularly useful for companies with volatile or temporarily depressed earnings, as revenue tends to be more stable than profits. It answers: "At what price has the market historically valued each dollar of this company's sales?"

Example: Fair Value (Revenue) 2022 = Revenue per Share 2022 × Average P/S 2019–2021

Dividend-Based Fair Value

Calculated by dividing the dividend per share by the average historical dividend yield. This approach is most relevant for mature, consistently dividend-paying companies. If the resulting fair value is higher than the current price, it implies the stock offers a better yield than its historical average.

Example: Fair Value (Dividend) 2022 = Dividend per Share 2022 ÷ Average Yield 2019–2021

How to Use This Chart

When all three fair value lines converge above the current price, it strengthens the case that the stock is undervalued. When they diverge, investigate why — it may indicate a structural shift in margins, payout policy, or growth rate. The forward estimates on the right extend the analysis using projected fundamentals, helping you assess whether the current price already reflects future growth expectations.

Trinity Biotech historical P/E ratio, EBIT multiple, and P/S ratio

Trinity Biotech annual returns

Details

Annual Return

ⓘ

What This Chart Shows

This chart breaks down 's total annual return into two components: price return (gains or losses from stock price movement) and dividend return (income received from dividend payments). Together, they represent the total return an investor would have earned in each calendar year.

Price Return

Price return measures the percentage change in 's stock price from January 1st to December 31st of each year. Positive bars indicate the stock appreciated; negative bars show a decline. This is the component most investors focus on, but it tells only part of the story — especially for dividend-paying stocks.

Dividend Return

Dividend return represents the income generated from dividends paid during the year, expressed as a percentage of the starting stock price. While it may seem small in any single year (typically 1–4 % for established companies), dividends compound significantly over decades and have historically contributed roughly 40 % of total stock market returns.

What to Look For

Examine how many years showed positive vs. negative returns to gauge consistency. A stock with mostly positive years and small drawdowns suggests lower risk. Also compare 's annual returns to a benchmark index — consistently outperforming the market is a hallmark of a strong investment. Pay attention to the worst years: understanding downside risk is just as important as chasing upside potential.

Trinity Biotech shares outstanding

The number of shares of Trinity Biotech was 70.64 M in 2025. This indicates how many shares Trinity Biotech is divided into. Since shareholders are the owners of a company, each share represents a small portion of the company's ownership.

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Number of stocks
Details
Date
Number of stocks
Jan 1, 2019
16.72 M Stocks
Jan 1, 2020
16.72 M Stocks
Jan 1, 2021
16.72 M Stocks
Jan 1, 2022
26.99 M Stocks
Jan 1, 2023
30.62 M Stocks
Jan 1, 2024
70.64 M Stocks
Jan 1, 2025 (e)
70.64 M Stocks
Jan 1, 2026 (e)
70.64 M Stocks

Trinity Biotech stock splits

In Trinity Biotech's history, there have been no stock splits.

Trinity Biotech Dividend History

5 years of dividend payments

YearAnnual DividendYoY ChangePayments
20150.22USD 0.0%1×
20140.22USD↑ 10.0%1×
20130.20USD↑ 33.3%1×
20120.15USD↑ 50.0%1×
20110.10USD—1×

Trinity Biotech dividend history and estimates

In 2025, Trinity Biotech paid a dividend amounting to 1.15 USD. Dividend means that Trinity Biotech distributes a portion of its profits to its owners.

  • Max

Dividend
Dividend (Estimate)
Special dividend
Details
Date
Dividend
Dividend (Estimate)
Special dividend
Jan 1, 2011 (e)
0.10 USD
0.00 USD
0.00 USD
Jan 1, 2012 (e)
0.15 USD
0.00 USD
0.00 USD
Jan 1, 2013
0.20 USD
0.00 USD
0.00 USD
Jan 1, 2014
0.22 USD
0.00 USD
0.00 USD
Jan 1, 2015
0.22 USD
0.00 USD
0.00 USD
Jan 1, 2025 (e)
0.00 USD
1.15 USD
0.00 USD
Jan 1, 2026 (e)
0.00 USD
1.21 USD
0.50 USD

Trinity Biotech dividend payout ratio

In 2025, Trinity Biotech had a payout ratio of 127.96%. The payout ratio indicates the percentage of the company's profits that Trinity Biotech distributes as dividends.

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Payout ratio
Details
Date
Payout ratio
Jan 1, 2019
130.73 %
Jan 1, 2020
126.84 %
Jan 1, 2021
127.62 %
Jan 1, 2022
128.40 %
Jan 1, 2023
127.62 %
Jan 1, 2024
127.88 %
Jan 1, 2025 (e)
127.96 %
Jan 1, 2026 (e)
127.82 %

Current Trinity Biotech forecasts and price targets in August 2026

Analyst Price Targets 2026
Δ MOM Price Target
0.00 %
Buy
85.71 % (6)
Hold
14.29 % (1)
Sell
0.00 % (0)
12M Price Target
4.08
Last Price
10.98
Currency
USD
12M Return Potential
-62.84 %
LTM Return
0 %

Trinity Biotech Earnings Estimates & Surprises

DateEPS estimateEPS ActualRevenue EstimatePrice reactionQuarterly report
4/3/2026-0.17USD-18.36 MUSD-2025 Q4
8/13/2025-0.24USD-17.85 MUSD-2025 Q2
12/14/2022-0.04USD-19.79 MUSD-2022 Q3
11/3/2022-0.30USD-18.74 MUSD-2022 Q2
6/30/2022-0.04USD-20.30 MUSD-2022 Q1
4/11/20220.07USD-24.36 MUSD-2021 Q4
5/25/20210.07USD--USD-2021 Q1
3/25/20210.14USD-28.42 MUSD-2020 Q4
11/17/20200.10USD-28.42 MUSD-2020 Q3
3/31/20200.06USD--USD-2019 Q4

EESG©

Eulerpool ESG Scorecard© for the Trinity Biotech stock

17/100
17
Environment
32
Social
1
Governance
E

Environment

20
Scope 1 - Direct Emissions—
Scope 2 - Indirect emissions from purchased energy—
Scope 3 - Indirect emissions within the value chain—
Total CO₂ emissions—
CO₂ reduction strategy
Coal energy
Nuclear power
Animal experiments
Fur & Leather—
Pesticides—
Palm Oil—
Tobacco
Genetically modified organisms
Climate concept—
Sustainable forestry—
Recycling regulations
Environmentally friendly packaging
Hazardous substances
Fuel consumption and efficiency
Water consumption and efficiency
S

Social

20
Percentage of female employees—
Percentage of women in management—
Percentage of Asian employees—
Share of Asian management—
Percentage of Hispanic/Latino employees—
Hispano/Latino Management share—
Percentage of Black employees—
Black Management Share—
Percentage of white employees—
White Management Share—
Adult content
Alcohol
Weapons—
Firearms
Gambling
Military contracts
Human rights concept
Privacy concept—
Occupational health and safety
Catholic
G

Governance (Corporate Governance)

4
Environmental reporting
Stakeholder Engagement
Call Back Policies
Antitrust law

The Eulerpool ESG Scorecard© is the strictly copyrighted intellectual property of Eulerpool Research Systems. Any unauthorized use, imitation, or infringement will be actively pursued and may lead to significant legal consequences. For licenses, collaborations, or usage rights, please contact us directly via our contact form. Contact Form to us.

Trinity Biotech shareholder structure

% Name
0.50678%
Perceptive Advisors LLC
Perceptive Advisors LLC
0.13791%
Hunter Associates Investment Management LLC
Hunter Associates Investment Management LLC
0.00727%
Moss Adams Wealth Advisors LLC
Moss Adams Wealth Advisors LLC
0.00357%
Commonwealth Financial Network
Commonwealth Financial Network
0.00340%
Williams & Novak Wealth Management, LLC
Williams & Novak Wealth Management, LLC
0.00283%
Inspirion Wealth Advisors, LLC
Inspirion Wealth Advisors, LLC

Trinity Biotech Executives and Management Board

11 members · avg. age 55 · 18 % women

JG

Mr. John Gillard (43)

President, Chief Executive Officer, Executive Director · since 2020

975,000.00 USD

Management

SO

Ms. Susan O'Connor

Interim Chief Financial Officer

–
GK

Dr. Gary Keating (51)

Chief Technology Officer

–
EK

Ms. Eibhlin Kelly (40)

Chief Information Officer

–
MW

Dr. Matthew Wictome

Vice President - Quality and Regulatory Affairs

–
ER

Mr. Eric Ribner

Investors Relations · since 2023

–

Board of Directors

RO

Mr. Ronan O'caoimh (68)

Founder, Executive Director · since 1992

84,000.00 USD
JW

Dr. James Walsh (65)

Executive Director - Business Development · since 2005

83,000.00 USD
TL

Mr. Tom Lindsay (67)

Non-Executive Independent Director

57,000.00 USD
AO

Mr. Andrew Omidvar

Non-Executive Independent Director

57,000.00 USD
CM

Mr. Colm Molloy (53)

Group Director of Human Resources and Culture

–

Trinity Biotech Supply Chain

Trinity Biotech Supply Chain

Correlation: how closely stock prices move together

Same directionNo relationOpposite
1 companies
#NameTrend
1
Abbott Laboratories
Supplier·Customer·Health Care Equipment & Supplies·US
-0.86
-0.79
-0.13
0.59
-0.31
-0.16

Frequently asked questions about Trinity Biotech

Analysts currently set an average price target of 4.08 USD for the Trinity Biotech stock (median: 4.08 USD), implying -62.8 % versus the latest price. The consensus is based on 7 analyst ratings.

Trinity Biotech Analyst Price Targets 2026

7 analysts currently rate the Trinity Biotech stock: 6 recommend buying, 1 holding and 0 selling. For 2026, analysts expect Trinity Biotech to generate revenue of 79.05 M USD and earnings per share of -2.50 USD.

Trinity Biotech Analyst Price Targets 2026

Converted at the current exchange rate, the Trinity Biotech share trades at 9.51 EUR (10.98 USD).

The Trinity Biotech share (TRIB) is listed on 4 stock exchanges, including: NASDAQ (TRIB), Frankfurt (TRBA.F), München (TRBA.MU), Düsseldorf (TRBA.DU).

No history available for Trinity Biotech.

The expected revenue of Trinity Biotech is 79.05 M USD. This figure is based on current financial data and reflects the company's business performance.

The expected profit of Trinity Biotech is -176.53 M USD. The net profit reflects the company's profitability after deducting all expenses.

The price-to-earnings ratio (P/E) of Trinity Biotech is currently -4.39. The P/E ratio compares the current share price to the earnings per share and helps investors assess the valuation of the Trinity Biotech stock.

The price-to-sales ratio (P/S) of Trinity Biotech is currently 9.81. The P/S ratio compares the market capitalization to the annual revenue and serves as a valuation metric for the Trinity Biotech stock.

The Eulerpool Quality Score for Trinity Biotech is 1/10.

The ISIN of Trinity Biotech is US8964385046. The ISIN (International Securities Identification Number) is a globally unique identifier for securities.

The WKN of Trinity Biotech is A0ET3S. The WKN (Wertpapierkennnummer) is a six-digit German security identification number.

The ticker of Trinity Biotech is TRIB. The ticker symbol is used to trade Trinity Biotech shares on the stock exchange.

Over the past 12 months, Trinity Biotech paid a dividend of 0.22 USD . This corresponds to a dividend yield of about 2.00 %. For the coming 12 months, Trinity Biotech is expected to pay a dividend of 1.15 USD.

The current dividend yield of Trinity Biotech is 2.00 %.

Trinity Biotech pays a dividend, distributed in the months of , , , .

Trinity Biotech paid dividends every year for the past 0 years.

For the upcoming 12 months, dividends amounting to 1.15 USD are expected. This corresponds to a dividend yield of 10.51 %.

Trinity Biotech is assigned to the 'Health' sector.

To receive the latest dividend of Trinity Biotech from amounting to 0.22 USD, you needed to have the stock in your portfolio before the ex-date on .

The last dividend was paid out on .

The dividends of Trinity Biotech are distributed in USD.

All fundamentals and in-depth analysis of Trinity Biotech

Our stock analysis for Trinity Biotech stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Trinity Biotech. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.

Trinity Biotech Stock
Trinity Biotech Revenue→
Trinity Biotech Stock
Trinity Biotech Net Income→
Trinity Biotech Stock
Trinity Biotech P/E→
Trinity Biotech Stock
Trinity Biotech P/S→
Trinity Biotech Stock
Trinity Biotech EBIT→
Trinity Biotech Stock
Trinity Biotech Dividend→
Trinity Biotech Stock
Trinity Biotech Directors Dealings→
Trinity Biotech Stock
Trinity Biotech Stocks→
Trinity Biotech Stock
Trinity Biotech Market capitalization→
Trinity Biotech Stock
Trinity Biotech Debt→
Trinity Biotech Stock
Trinity Biotech Liabilities→
Trinity Biotech Stock
Trinity Biotech Equity→
Trinity Biotech Stock
Trinity Biotech AAQS→
Trinity Biotech Stock
Trinity Biotech Employees→
Trinity Biotech Stock
Trinity Biotech ROE→
Trinity Biotech Stock
Trinity Biotech ROA→
Trinity Biotech Stock
Trinity Biotech ROCE→
Trinity Biotech Stock
Trinity Biotech News→
Trinity Biotech Stock
Trinity Biotech Analyst Price Targets→

Health Stocks

TriSalus Life SciencesTrident LifelineTristelTrevi TherapeuticsTrivarXTrevenaTruBridgeTreace Medical ConceptsTruking TechnologyTraws PharmaTruscreen GroupTravere TherapeuticsAll Stocks A–Z →